New hope for rare disease patients: study tests three rescue treatments for stubborn vasculitis

NCT ID NCT04871191

Recruiting now Disease control Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

First seen Apr 03, 2026 · Last updated May 20, 2026 · Updated 2 times

Summary

This study is for people with granulomatosis with polyangiitis, a rare disease where blood vessels get inflamed, who haven't improved with usual treatments. It compares three different drug combinations to see which works best to control the disease. About 42 adults will take part, and the goal is to reduce symptoms and prevent flare-ups, though ongoing medication is still needed.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Hôpital de la Croix Saint Simon
RECRUITING

Paris, 75020, France

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS GRANULOMATOSIS WITH POLYANGIITIS